Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma.

A trend was observed in which patients with lower expression levels of MDMX were more likely to achieve disease control than were patients with higher MDMX levels, although this association did not reach statistical significance.

also in 111,027 other papers